News & Media

Latest Press Release

December 6, 2018

BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic

Leading Institution to Become the Second Center after TCAI to Launch the Studies with PURE EP System Santa Monica, CA, Dec. 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has signed an agreement with Mayo Clinic to conduct First-in-Human studies using the PURE EP™…

Read More